Systems Biology of Gastrointestinal and Related Diseases
NCT ID: NCT05579444
Last Updated: 2023-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
17 participants
OBSERVATIONAL
2022-11-11
2023-11-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Demographics and Findings of Upper Endoscopy Patients
NCT00576992
A Study to Examine the Human Gastrointestinal Tract Using the Confocal Endomicroscope
NCT01262937
Study of Gastric Motility in Eosinophilic Gastritis
NCT05229432
High Definition White Light Endoscopy and Narrow Band Imaging for the Assessment of Barrett's Disease After Endoscopic Therapy
NCT01360801
Intestinal Permeability and Gastroparesis
NCT04894656
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ulcerative Colitis
Participants with ulcerative colitis.
No interventions assigned to this group
Crohn's Disease
Participants with Crohn's disease.
No interventions assigned to this group
Obesity
Participants that are obese.
No interventions assigned to this group
Colon Polyps
Participants with colon polyps.
No interventions assigned to this group
Eosinophilic esophagitis
Participants with Eosinophilic esophagitis
No interventions assigned to this group
Gastroesophageal Reflux Disease (GERD)
Participants with Gastroesophageal Reflux Disease (GERD).
No interventions assigned to this group
Gastritis
Participants with gastritis.
No interventions assigned to this group
Gastric ulcers
Participants with gastric ulcers.
No interventions assigned to this group
Duodenal ulcers
Participants with duodenal ulcers.
No interventions assigned to this group
Intestinal metaplasia
Participants with intestinal metaplasia (risk factor for esophageal cancer).
No interventions assigned to this group
Gastric Cancer
Participants with gastric cancer.
No interventions assigned to this group
Lymphocytic/Microscopic Colitis
Participants with Lymphocytic/Microscopic Colitis.
No interventions assigned to this group
Celiac Sprue
Participants with Celiac Sprue.
No interventions assigned to this group
Irritable Bowel Syndrome (IBS)
Participants with IBS.
No interventions assigned to this group
Small intestinal bacterial overgrowth (SIBO)
Participants with SIBO.
No interventions assigned to this group
Non-alcoholic Fatty Liver Disease (NAFLD)
Participants with NAFLD.
No interventions assigned to this group
Gallstone disease
Participants with Gallstone disease.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to use electronic communications
* Able to communicate in English
* Consent to participate in the study
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Viome
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Momchilo Vuyisich
Role: PRINCIPAL_INVESTIGATOR
Viome
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Viome Life Sciences
Bothell, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
V263
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.